Alopecia Areata: Pathogenesis, Current Treatments, and Future Perspectives
March 2025
in “
Journal of Education Health and Sport
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary This review, drawing on scientific literature, explores alopecia areata's pathogenesis and treatment, noting that while therapies like JAK inhibitors show promise, there remains a significant need for more effective and targeted solutions, and a better understanding of the disease mechanisms.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Alopecia areata (AA) is a chronic autoimmune disorder characterized by non-scarring hair loss due to immune dysregulation, specifically the destruction of hair follicles by autoreactive T-cells. Treatment options depend on the severity of the disease, with topical therapies used for limited hair loss and systemic therapies for more severe cases. Recent advancements in treatment include Janus kinase (JAK) inhibitors, which have shown promise in clinical trials for refractory AA, and emerging stem cell-based therapies. Despite these advancements, there remains a significant unmet medical need, as no universally effective treatment exists. Further research is essential to better understand the pathogenesis of AA and to develop more effective therapies.
